Journals / Medicine Science / 2019 / Cilt: 8 - Sayı: 2

Effects of L-Carnitine and N-Acetylcysteine on nonalcoholic hepatic steatosis in rats

Pages
401–406
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, these findings must be confirmed by further studies including larger populations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:This study was performed to investigate whether the antioxidants L-carnitine and N-acetylcysteine (NAC) have therapeutic effects on Nonalcoholic hepatic steatosis (NHS) in rats with carbon tetrachloride (CCl4)-induced fatty liver disease.
📊
Key Findings & Data:Twenty-four healthy male and female Wistar Albino rats, weighing 220–250 g and obtained from our university health research institute, were used in this study.
💡
Conclusion & Impact:However, these findings must be confirmed by further studies including larger populations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

This study was performed to investigate whether the antioxidants L-carnitine and N-acetylcysteine (NAC) have therapeutic effects on Nonalcoholic hepatic steatosis (NHS) in rats with carbon tetrachloride (CCl4)-induced fatty liver disease. Twenty-four healthy male and female Wistar Albino rats, weighing 220–250 g and obtained from our university health research institute, were used in this study. The animals were divided into four groups of six rats each: Group 1 [Diet + normal saline solution (NSS), control group], Group 2 [Diet + CCl4], Group 3 [Diet + CCl4 + L-carnitine] and Group 4 [Diet + CCl4 + NAC]. For biochemical examinations blood samples were obtained from the right ventricle of the heart and liver samples for histopathological were also obtained. The mean Aspartate aminotransferase (AST) (P = 0.043) and lactate dehydrogenase (LDH) levels (P=0.021) were significantly lower in rats with l-carnitine treatment. The mean ALT level were significantly lower in rats with NAC and (P = 0.014). Microscopic steatosis severity was decreased in the rats with NAC treatment than the controls. However administration of l-carnitine did not sufficiently prevent hepatic steatosis or inflammation. Our study showed that L-carnitine and NAC treatment resulted in significant regression of steatosis in rats with NHS. However, these findings must be confirmed by further studies including larger populations.

🔖

Cite This Article

NAS, C., GÖKDEMİR, M. T., CANORUC, N., YALDİZ, M. (2019). Effects of L-Carnitine and N-Acetylcysteine on nonalcoholic hepatic steatosis in rats. Medicine Science, Cilt: 8 - Sayı: 2, 401–406. https://ajindex.com/articles/277857

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Lee MR, Park KI, Ma JY. Leonurus japonicus Houtt attenuates nonalcoholic fatty liver disease in free fatty acid-induced HEPG2 cells and mice fed a highfat diet. Nutrients. 2018;10:20. Erkan G, MuratogluS, Ercin U, et al. Angiopoietin-like protein 2 and angiopoietin-like protein 6 levels in patients with nonalcoholic fatty liver disease. Arch Med Sci. 2018;14:81-7.
  2. Hardy T, Oakley F, Anstee QM, et al. Nonalcoholic fatty liver disease: pathogenesis and disease spectrum. Annu. Rev. Pathol. 2016;11:451-96.
  3. Zarei M, Barroso E, Palomer X et al. Hepatic regulation of VLDL receptor by PPAR β/δ and FGF 21 modulates non-alcoholic fatty liver disease. Mol Metabol. 2018;8:117-31.
  4. Bodaghi-Namileh V, Sepand MR, Omidi A et al. Acetyl-L-carnitine attenuates arsenic-induced liver injury by abrogation of mitochondrial dysfunction, inflammation, and apoptosis in rats. Environ. Toxicol. Pharmacol. 2018;58:1120. Angulo P, Deach JC, Batts KP, et al. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology. 1999;30:1356-62.
  5. S Yuan D, Xiang T, Huo Y. Preventive effects of total saponins of Panax japonicus on fatty liver fibrosis in mice. Arch Med Sci. 2018;14:396–406.
  6. Nabi T, Nabi S, Rafiq N, et al. Role of N-acetylcysteine treatment in nonacetaminophen-induced acute liver failure: A prospective study. Saudi. J. Gastroenterol. 2017;23:169-75.
  7. Peverill W, Powell LW, Skoien R. Evolving concepts in the pathogenesis of NASH: beyond steatosis and inflammation. Int J Mol Sci. 2014;15:8591-638. García-Alcántara F, Murillo-Cuesta S, Pulido S et al. The expression of oxidative stress response genes is modulated by a combination of resveratrol and N-acetylcysteine to ameliorate ototoxicity in the rat cochlea. Hear Res. 2017;14;358:10-21.
  8. Choi JW, Ohn JH, Jung HS et al. Carnitine induces autophagy and restores high-fat diet-induced mitochondrial dysfunction. Metabolism C linical and E xperimental. 2017;78:43-51.
  9. Moghaddas A, Dashti-Khavidaki S. Potential protective effects of L-Carnitine against neuromuscular ischemia-reperfusion injury: From experimental data to potential clinical applications. Clin. Nutr. 2016;35:783-90.
  10. Bae CJ, Lee WY, Yoon KH et al. Improvement of nonalcoholic fatty liver disease with carnitine-orotate complex in type 2 diabetes (CORONA): a randomized controlled trial. Diabetes Care. 2015;38:1245-52.
  11. Shaw S, Rubin KP, Liyeber CS. Depressed hepatic glutathione and increased diene conjugates in alcoholic liver disease: evidence o